We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Trin Therapeutics GmbH.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01259518
First Posted: December 14, 2010
Last Update Posted: June 8, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University Hospital, Essen
Central European Society for Anticancer Drug Research
Assign Data Management and Biostatistics GmbH
Information provided by:
Trin Therapeutics GmbH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2012
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)